Physician profile
Brian K Mitchell
NPI 1982059754
$4,461.90
in general payments reported to CMS, 2019-2025
30 companies · $2,109 in 2025
The $2,109 reported for 2025 was more than what 84% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $117 · 2023: $964 · 2024: $1,273 · 2025: $2,109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,322 · Travel and Lodging: $1,477 · Education: $275 · Grant: $272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,321.89 |
| Travel and Lodging | $1,476.57 |
| Education | $274.99 |
| Grant | $271.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,237.81 | 2023-2025 | Xience Skypoint, Ultreon, Diamondback Coronary |
| Shockwave Medical, INC | $617.09 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $271.74 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $172.20 | 2023-2025 | Tagrisso, Enhertu |
| Philips North America LLC | $141.44 | 2024 | (Bq9) Coronary Ivus, (Br0) Coronary Atherectomy |
| Medtronic, INC. | $128.21 | 2023 | Telescope |
| Edwards Lifesciences Corporation | $126.76 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Zoll Circulation INC | $113.30 | 2025 | Catheter, Downstream Cartridge, Therox Ds2 Console |
| Genentech USA, INC. | $78.29 | 2022-2025 | Tecentriq |
| Chiesi USA, INC. | $72.00 | 2023 | Kengreal |
| Takeda Pharmaceuticals U.S.A., INC. | $56.84 | 2024 | Vpriv |
| Cook Medical LLC | $48.79 | 2023 | Zenith Alpha |
| Mirati Therapeutics, INC. | $46.70 | 2023 | Krazati |
| Pfizer INC. | $29.34 | 2025 | |
| Celltrion USA INC. | $26.24 | 2023 | Vegzelma |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $25.79 | 2024 | Jemperli, Zejula |
| Karyopharm Therapeutics INC. | $24.84 | 2024 | Xpovio |
| Canon Medical Systems USA, INC. | $23.62 | 2024 | Interventional Angiography System |
| Stemline Therapeutics INC. | $23.44 | 2023 | Orserdu |
| Jazz Pharmaceuticals INC. | $22.48 | 2023 | Zepzelca |
| Seagen INC. | $21.12 | 2022 | |
| Kite Pharma, INC. | $20.51 | 2022 | |
| G1 Therapeutics, INC. | $20.29 | 2022 | |
| Pharmacosmos Therapeutics INC. | $19.93 | 2024 | Monoferric |
| Daiichi Sankyo INC. | $18.77 | 2024 | Injectafer |
| Emd Serono, INC. | $17.60 | 2025 | |
| Servier Pharmaceuticals LLC | $17.55 | 2023 | |
| Novocure INC. | $17.19 | 2023 | |
| Genmab U.S., INC. | $16.62 | 2024 | Epkinly |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $5.40 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.